| Parkinson Disease |
1 |
1 |
| Depression |
0 |
0.99 |
| Lewy Body Dementia |
0 |
0.51 |
| HIV Infection |
0 |
0.47 |
| Dementia |
0 |
0.98 |
| Sleep Disorders |
0 |
0.43 |
| Sleep |
0 |
0.36 |
| Antidepressant drug |
0 |
0.34 |
| Cyclic Antidepressants |
0 |
0.32 |
| Hallucination |
0 |
0.29 |
| New York |
0 |
0.29 |
| Delusions |
0 |
0.22 |
| Dopaminergic |
0 |
0.22 |
| Psychosis |
0 |
0.97 |
| Cognitive Impairment |
0 |
0.21 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.17 |
| Mild Cognitive Impairment |
0 |
0.17 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.15 |
| Impairment |
0 |
0.14 |
| Mental Illness |
0 |
0.14 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.14 |
| Receptors |
0 |
0.14 |
| Dopamine Agonists |
0 |
0.1 |
| Rapid Eye Movement |
0 |
0.1 |
| Constipation |
0 |
0.09 |
| Weight Management |
0 |
0.09 |
| Anticholinergic Drug |
0 |
0.07 |
| Behavioral Problem |
0 |
0.07 |
| Blood |
0 |
0.07 |
| Brain |
0 |
0.07 |
| Dopamine |
0 |
0.07 |
| Drug Interaction |
0 |
0.07 |
| Food and Drug Administration (FDA) |
0 |
0.07 |
| Insomnia |
0 |
0.07 |
| Memory |
0 |
0.07 |
| Movement Disorder |
0 |
0.07 |
| Orbit |
0 |
0.07 |
| Psychopharmacology |
0 |
0.07 |
| Serotonin Syndrome |
0 |
0.07 |
| Sexual Dysfunction |
0 |
0.07 |
| Tremor |
0 |
0.07 |
| Urinary Retention |
0 |
0.07 |
| Weight Gain |
0 |
0.07 |